收藏切换
Research Progress on Proteolysis Targeting Chimeras
收藏切换
Hengyuan MA1, 2, Zhiqiang KE3, Zhengding SU1, *
Chinese Journal of Pharmaceuticals | 2024, 55(11) : 1467 - 1476
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2024, 55(11): 1467-1476
• Review •
Research Progress on Proteolysis Targeting Chimeras
Full
Hengyuan MA1, 2, Zhiqiang KE3, Zhengding SU1, *
Affiliations
  • 1.Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), Hubei University of Technology, Wuhan 430068
  • 2.Jiangsu Hengrui Pharmaceuticals Co., Ltd., Lianyungang 222000
  • 3.Hubei Key Lab. of Diabetes and Angiopathy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100
Published: 2024-11-10 doi: 10.16522/j.cnki.cjph.2024.11.002
Outline
收藏切换

Traditional small molecule kinase inhibitor drugs face numerous challenges, such as the propensity for drug resistance and the problem that some targets are undruggable. The proteolysis targeting chimera(PROTAC) technology utilizes the inherent ubiquitin-proteasome system in cells to achieve the degradation of proteins of interest(POI) for treating diseases, which can avoid the limitations of undruggable targets and drug resistance. Therefore, the PROTAC technology is expected to overcome the limitations of small molecule inhibitors. At present, some PROTACs have entered the clinical trial stage and are expected to become potential treatment methods for many diseases. This review introduces the biological mechanism, technical advantages, molecular design and clinical application prospects of PROTAC, hoping to provide a reference for its drug development and clinical application.

undruggable target  /  ubiquitin-proteasome system  /  proteolysis targeting chimera  /  clinical trial  /  research progress
马恒元, 柯志强, 苏正定. 蛋白降解靶向嵌合体的研究进展. 中国医药工业杂志, 2024 , 55 (11) : 1467 -1476 . DOI: 10.16522/j.cnki.cjph.2024.11.002
Hengyuan MA, Zhiqiang KE, Zhengding SU. Research Progress on Proteolysis Targeting Chimeras[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (11) : 1467 -1476 . DOI: 10.16522/j.cnki.cjph.2024.11.002
Year 2024 volume 55 Issue 11
27
7
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2024.11.002
  • Receive Date:2024-04-03
  • Online Date:2026-11-18
  • Published:2024-11-10
Article Data
Affiliations
History
  • Received:2024-04-03
Affiliations
    1.Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), Hubei University of Technology, Wuhan 430068
    2.Jiangsu Hengrui Pharmaceuticals Co., Ltd., Lianyungang 222000
    3.Hubei Key Lab. of Diabetes and Angiopathy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.11.002
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT